drugset / Trial / NCT01172431

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

NCT01172431

Phase 4 Completed 240 enrolled West China Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of indapamide SR 1.5 mg on renal function, endothelial function, blood pressure variability by comparison with hydrochlorothiazide 25 mg, in patients with Mild to Moderate Renal Insufficiency and Hypertension.

Timeline

Start
2010-09
Primary completion
2012-03
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochlorothiazide Unknown 25 mg
Subject Indapamide Small molecule 1.5 mg